---
title: "Emgee Cables & Communication Ltd (530333) — Share Price, Financials & Analysis"
symbol: "530333"
company: "Emgee Cables & Communication Ltd"
canonical: "https://tapetide.com/stocks/530333"
isin: "INE128F01010"
bse_code: "530333"
sector: "Industrials"
industry: "Electrical Equipment"
generated_at: "2026-09-13T19:49:43.684Z"
---

# Emgee Cables & Communication Ltd (530333)

Canonical page: https://tapetide.com/stocks/530333

## Company

- **BSE Code:** 530333
- **ISIN:** INE128F01010
- **Sector:** Industrials
- **Industry:** Electrical Equipment
- **Macro Sector:** Industrials
- **Stock Type:** EQUITY
- **Listed Since:** 2010-10-22
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** emgeecables.com

## About

Emgee Cables & Communication Ltd. is Indias leading manufacturer of Submersible Wire & Cables and enjoys an enviable reputation as a quality manufacturer.

## Latest Price

- **Price:** ₹2.94
- **Change:** +0.14 (+5%)
- **Open:** ₹2.94
- **Day High:** ₹2.94
- **Day Low:** ₹2.94
- **Previous Close:** ₹2.8
- **Volume:** 300
- **As Of:** 2020-05-22T03:32:40+00:00

## Key Insights

### Strengths

- Stock is trading at 0.09 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 2.90% over past five years.
- Company has a low return on equity of 3.97% over last 3 years.
- Contingent liabilities of Rs.25.0 Cr.
- Company has high debtors of 160 days.
- Company's cost of borrowing seems high

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | 16% | 25% | -1% |
| revenue growth | 13% | 5% | 3% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 39.62 | 37.59 | 28.49 | 33.8 | 46.72 | 41.82 | 38.22 | 42.91 | 52.33 | 47.9 | 38.53 | 53.46 |
| Expenses | 37.29 | 36.05 | 26.9 | 31.32 | 41.54 | 39.35 | 35.55 | 40.5 | 48.97 | 44.95 | 34.89 | 49.89 |
| Operating Profit | 2.33 | 1.54 | 1.59 | 2.48 | 5.18 | 2.47 | 2.67 | 2.41 | 3.36 | 2.95 | 3.64 | 3.57 |
| OPM % | 5.88 | 4.1 | 5.58 | 7.34 | 11.09 | 5.91 | 6.99 | 5.62 | 6.42 | 6.16 | 9.45 | 6.68 |
| Other Income | 0.09 | 0.07 | 0.35 | 0.03 | 0 | 0.05 | 0.11 | 0 | 0.1 | 0.04 | 0.05 | 0.08 |
| Interest | 2.18 | 1.32 | 1.41 | 2.21 | 4.68 | 1.97 | 2.36 | 2.03 | 2.89 | 2.45 | 3.3 | 2.95 |
| Depreciation | 0.11 | 0.13 | 0.12 | 0.14 | 0.25 | 0.19 | 0.13 | 0.18 | 0.18 | 0.14 | 0.14 | 0.14 |
| Profit before tax | 0.13 | 0.16 | 0.41 | 0.16 | 0.25 | 0.36 | 0.29 | 0.2 | 0.39 | 0.4 | 0.25 | 0.56 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 30.56 | 31.03 | 30 | 58.97 | 30 | 28 | 30.36 |
| Net Profit | 0.13 | 0.16 | 0.41 | 0.17 | 0.25 | 0.25 | 0.21 | 0.14 | 0.15 | 0.28 | 0.17 | 0.39 |
| EPS in Rs | 0.3 | 0.36 | 0.93 | 0.39 | 0.46 | 0.46 | 0.39 | 0.26 | 0.28 | 0.52 | 0.31 | 0.72 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 84 | 110 | 140 | 152 | 150 | 151 | 150 | 147 | 175 | 192 |
| Expenses | 81 | 109 | 136 | 147 | 144 | 145 | 143 | 136 | 164 | 179 |
| Operating Profit | 3 | 0 | 5 | 5 | 6 | 7 | 7 | 11 | 11 | 14 |
| OPM % | 3.4 | 0.3 | 3.4 | 3.2 | 4 | 4.4 | 4.9 | 8 | 6 | 7 |
| Other Income | 1 | 4 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Interest | 2 | 3 | 4 | 4 | 6 | 7 | 6 | 10 | 9 | 12 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit before tax | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 2 |
| Tax % | 92 | 28 | 32 | 21 | 81 | 32 | 21 | 39 | 40 | — |
| Net Profit | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
| EPS in Rs | 0.16 | 1.54 | 1.68 | 1.79 | 0.11 | 0.86 | 1.07 | 1.15 | 1.39 | 1.83 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Sep 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 7 |
| Reserves | 8 | 8 | 9 | 10 | 10 | 10 | 10 | 11 | 12 | 12 |
| Borrowings | 14 | 17 | 20 | 19 | 23 | 25 | 22 | 30 | 41 | 38 |
| Other Liabilities | 8 | 10 | 12 | 18 | 20 | 23 | 25 | 46 | 73 | 69 |
| Total Liabilities | 35 | 39 | 45 | 51 | 57 | 63 | 62 | 93 | 131 | 125 |
| Fixed Assets | 6 | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 5 | 4 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 27 | 34 | 40 | 46 | 52 | 58 | 58 | 88 | 126 | 121 |
| Total Assets | 35 | 39 | 45 | 51 | 57 | 63 | 62 | 93 | 131 | 125 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -2 | -5 | — | — | -2 | -5 | -3 | 10 | 1 | 0 |
| Cash from Investing Activity | -1 | 0 | — | — | 1 | 1 | 1 | 0 | -2 | 0 |
| Cash from Financing Activity | 2 | 1 | — | — | 1 | 4 | 2 | -10 | 1 | 1 |
| Net Cash Flow | -2 | -4 | — | — | 0 | 0 | 0 | 0 | 0 | 1 |
| Free Cash Flow | -5 | -5 | — | — | -2 | -6 | -3 | 10 | -1 | 0 |
| CFO/OP | -2025 | -176 | — | — | -34 | -89 | -42 | 135 | 12 | 5 |

### Ratios

| Item | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 28 | 36 | 48 | 49 | 59 | 62 | 86 | 83 | 109 | 160 |
| Inventory Days | 56 | 55 | 38 | 37 | 38 | 48 | 43 | 46 | 85 | 94 |
| Days Payable | 48 | 32 | 29 | 27 | 41 | 44 | 54 | 61 | 120 | 147 |
| Cash Conversion Cycle | 36 | 58 | 57 | 59 | 57 | 67 | 74 | 69 | 74 | 108 |
| Working Capital Days | 73 | 80 | 77 | 18 | 21 | 20 | 20 | 22 | 61 | 57 |
| ROCE % | 10 | 13 | 14 | 15 | 15 | 16 | 18 | 18 | 26 | 20 |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Mar 2018 | Jun 2018 |
| --- | --- | --- | --- |
| Promoters | 36.38% | 36.39% | 36.43% |
| DIIs | 0.92% | 0.92% | 0.93% |
| Public | 62.69% | 62.69% | 62.64% |
| No. of Shareholders | 2628 | 2635 | 2651 |

### Quarterly

| Category | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 37.28% | 36.4% | 36.4% | 36.38% | 36.39% | 36.39% | 36.39% | 36.39% | 36.43% |
| DIIs | 0.92% | 0.92% | 0.92% | 0.92% | 0.92% | 0.92% | 0.92% | 0.92% | 0.93% |
| Public | 61.79% | 62.68% | 62.68% | 62.69% | 62.69% | 62.69% | 62.69% | 62.69% | 62.64% |
| No. of Shareholders | 2631 | 2625 | 2627 | 2628 | 2635 | 2633 | 2620 | 2635 | 2651 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 5 / 2 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 3.17 | Sell |
| EMA (10) | 3.22 | Sell |
| SMA (20) | 3.95 | Sell |
| EMA (20) | 3.73 | Sell |
| SMA (50) | 4.92 | Sell |
| EMA (50) | 5.3 | Sell |
| SMA (100) | 8.77 | Sell |
| EMA (100) | 8.08 | Sell |
| SMA (200) | 14.08 | Sell |
| EMA (200) | 10.64 | Sell |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 23.49 | Buy |
| MACD (12,26,9) | -0.68 | Sell |
| Stochastic (14,3,3) | 2.78 | Buy |
| ADX (14) | 45.7 | Buy |
| Williams %R (14) | -91.67 | Buy |
| ATR (14) | 0.19 | High Volatility |
| ROC (12) | -30.99 | Sell |
| Stoch RSI (14) | 31.78 | Neutral |
| UO (7,14,28) | 19.01 | Buy |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Q3 FY26 investor presentation: Revenue ₹1,023cr, EBITDA ₹368cr (35.9%), PAT ₹277cr (27.3%), dated 9 Feb 2026 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 9 Feb - Q3 FY26 investor presentation: Revenue ₹1,023cr, EBITDA ₹368cr (35.9%), PAT ₹277cr (27.3%), dated 9 Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bc215724-313f-4123-9a0e-1583944b869b.pdf) |
| 9 Feb - Audio recording of analyst/institutional investor meetings uploaded; disclosure dated 6 Nov 2025. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 9 Feb - Audio recording of analyst/institutional investor meetings uploaded; disclosure dated 6 Nov 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d63dbc5f-582e-4c69-a3e0-3d30342c2adc.pdf) |
| 7h - Maharashtra GST order (Apr 2022–Mar 2023) demanding Rs.6,92,76,478 (tax+penalty); interest unquantified. | [Disclosure Under Regulations 30 7h - Maharashtra GST order (Apr 2022–Mar 2023) demanding Rs.6,92,76,478 (tax+penalty); interest unquantified.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/638309ce-842e-4e89-b08f-9388f3e414e0.pdf) |
| 7 Jan 2020 - Liquidator has modified the list of stakeholder in accordance with the section 42 of Insolvency and Bankruptcy Code, 2016 | [Corporate Insolvency Resolution Process (CIRP)-Liquidation - Corporate Insolvency Resolution Process (CIRP) 7 Jan 2020 - Liquidator has modified the list of stakeholder in accordance with the section 42 of Insolvency and Bankruptcy Code, 2016](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bf01da78-df74-4037-956b-36e0b6d9bedf.pdf) |
| 23 Feb - GST order dated 21 Jan 2026 demands Rs3,79,25,656 for FY2019-20 to FY2022-23. | [Disclosure Under Regulation 30 23 Feb - GST order dated 21 Jan 2026 demands Rs3,79,25,656 for FY2019-20 to FY2022-23.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ba75ddc9-eeb9-424e-acb9-b01dd7d65455.pdf) |
| 22 Oct 2019 - Hon''ble National Company Law Tribunal vide order dated 18.09.2019 passed order for the commencement of liquidation of the corporate debtor and vide order dated 25.09.2019 … | [Corporate Insolvency Resolution Process (CIRP)-Liquidation - Corporate Insolvency Resolution Process (CIRP) 22 Oct 2019 - Hon''ble National Company Law Tribunal vide order dated 18.09.2019 passed order for the commencement of liquidation of the corporate debtor and vide order dated 25.09.2019 …](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cb58264-a303-49c6-815b-f6763c80b5fe.pdf) |
| 22 Oct 2019 - Hon''ble National Company Law Tribunal vide order dated 18.09.2019 passed order for the commencement of liquidation of the corporate debtor and vide order dated 25.09.2019 … | [Corporate Insolvency Resolution Process (CIRP)-Liquidation - Corporate Insolvency Resolution Process (CIRP) 22 Oct 2019 - Hon''ble National Company Law Tribunal vide order dated 18.09.2019 passed order for the commencement of liquidation of the corporate debtor and vide order dated 25.09.2019 …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7cb58264-a303-49c6-815b-f6763c80b5fe.pdf) |
| 2 Mar - Ronojit Biswas appointed Whole-Time Director & CFO effective 1 April 2026; Juby Chandy steps down March 11, 2026. | [Board Meeting Outcome for Outcome Of Board Meeting 2 Mar - Ronojit Biswas appointed Whole-Time Director & CFO effective 1 April 2026; Juby Chandy steps down March 11, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/56ec471a-ae8c-4153-bbf4-36ed54804dba.pdf) |
| 2 Mar - Ronojit Biswas appointed Whole-Time Director & CFO effective 1 April 2026; Juby Chandy steps down 11 March 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 2 Mar - Ronojit Biswas appointed Whole-Time Director & CFO effective 1 April 2026; Juby Chandy steps down 11 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/51a12287-3d8b-4a30-b65f-9cfa0cc14950.pdf) |
| 16 Feb - Q3 FY26 earnings transcript: INR1,000 crore quarter, 8.1% growth, 35.9% EBITDA, oncology first-line approval expands eligible patients to ~6,000. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 16 Feb - Q3 FY26 earnings transcript: INR1,000 crore quarter, 8.1% growth, 35.9% EBITDA, oncology first-line approval expands eligible patients to ~6,000.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d19552c8-c917-4789-92f9-011ca0f57da1.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/50c88077-6708-452c-8af2-08dd1c068980.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/59ebf753-033f-40f4-ac54-fa8b6e063f12.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5100e2c6-6403-42f0-9a36-3733c85a2d13.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0ad14593-1179-49a4-820c-f5a9a3321097.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5466c9ee-0adb-445b-bdff-af657cc85fc1.pdf) |
| Mar 2023 | [Concall - Mar 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/043137a2-ffef-41c4-858e-f5ee1cb91d5b.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e701d690-a62a-4a30-8493-6a29f24cf007.pdf) |
| Feb 2024 | [Concall - Feb 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/82e8f7ff-585d-46d5-8c23-77842cc95cff.pdf) |
| Feb 2020 | [Concall - Feb 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/44b319f2-060d-404e-8a7e-82b5ee537ffd.pdf) |
| Aug 2024 | [Concall - Aug 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9cf9f819-1ed7-48ad-8dba-069e5b463645.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2013 from nse](https://archives.nseindia.com/annual_reports/AR_3217_GLAXO_2013_2013_24032014174919.zip) |
| from nse | [Financial Year 2012 from nse](https://archives.nseindia.com/annual_reports/AR_347_GLAXO_2012_2012_05072013102200.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/72fcf18f-8def-4198-9977-dfc64762d12c.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/08dba7e9-e85f-4c3d-a358-178b1d8c499c.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b6b29ed5-b0b2-40db-aa46-3efc83311bb8.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/500660/73292500660.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/500660/68671500660.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/500660/5006600320.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/500660/5006600319.pdf) |
| from bse | [Financial Year 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/500660/5006600318.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2020-09-08 | [Corporate Insolvency Resolution Process (CIRP)-Liquidation - Corporate Insolvency Resolution Process (CIRP)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0979bc25-1814-4ce7-9697-706b4f756dca.pdf) |
| 2020-01-07 | [Corporate Insolvency Resolution Process (CIRP)-Liquidation - Corporate Insolvency Resolution Process (CIRP)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf01da78-df74-4037-956b-36e0b6d9bedf.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:49:43.684Z.